Key Takeaways
- Bank of England held its key interest rate at 4% for the second consecutive meeting, with a 5-4 vote, signaling a cautious approach despite inflation remaining nearly double its 2% target.
- BMO Capital Markets significantly raised its price target for Eli Lilly (LLY) to $1,100 from $930, citing the pharmaceutical giant's increasing dominance in the lucrative obesity treatment market.
- Nvidia-backed Vast Data secured a substantial $1.17 billion AI commercial agreement with cloud provider CoreWeave, further solidifying the latter's position in the rapidly expanding accelerated computing sector.
- OPEC oil output continued to rise last month, though a recent OPEC+ decision to pause further increases in Q1 2026 suggests caution amid forecasts of potential oversupply.
- Warner Bros Discovery (WBD) reported mixed third-quarter results, with strong free cash flow of $701 million surpassing estimates, but missing expectations on subscriber additions, total revenue, streaming revenue, and adjusted EBITDA.
Market Highlights: Central Bank Stance, Pharma Gains, AI Expansion, and Energy Dynamics
Financial markets are digesting a series of significant announcements today, ranging from a cautious stance by the Bank of England to a substantial price target increase for Eli Lilly, major AI infrastructure deals, and mixed signals from the energy sector and media earnings.
Bank of England Holds Rates Amid Inflation Concerns
The Bank of England (BoE) today announced its decision to maintain the benchmark Bank Rate at 4%, marking the second consecutive meeting without a change. The Monetary Policy Committee (MPC) voted 5-4 to hold rates steady, with four members advocating for a 0.25 percentage point cut to 3.75%. This decision comes as UK inflation, while having peaked, remains at 3.8% in September, nearly double the BoE's 2% target. The central bank's Monetary Policy Report and a subsequent press conference are underway to provide further insights into their economic outlook and future policy path. The MPC is balancing persistent inflationary pressures with signs of slowing wage growth and economic weakness, while also considering the potential impact of the upcoming Autumn Budget on November 26.
Eli Lilly's Obesity Drug Dominance Drives Analyst Optimism
BMO Capital Markets has significantly boosted its price target for pharmaceutical giant Eli Lilly (LLY) to $1,100 from $930, while reiterating an "Outperform" rating. This upward revision reflects BMO's confidence in Eli Lilly's growing dominance in the obesity treatment market. The firm noted that prescriptions for Lilly's key obesity medications, Mounjaro and Zepbound, have recently surpassed those of competitor Novo Nordisk's (NVO) Ozempic and Wegovy. This market leadership has contributed to Eli Lilly's impressive 45.41% revenue growth over the past twelve months and a strong third-quarter earnings beat. The company also plans a $3 billion investment in a new manufacturing facility in the Netherlands to expand its capacity for oral medicines, including the anticipated orforglipron.
Vast Data and CoreWeave Forge $1.17 Billion AI Partnership
In the rapidly expanding artificial intelligence sector, Nvidia-backed Vast Data has inked a substantial $1.17 billion commercial agreement with cloud provider CoreWeave. This deal extends their existing partnership, focusing on building a global, Nvidia-powered accelerated computing cloud designed for generative AI, high-performance computing (HPC), and visual effects (VFX) workloads. CoreWeave, a GPU specialist cloud provider, is a key partner for Nvidia (NVDA), which has a separate $6.3 billion agreement to purchase any unsold cloud capacity from CoreWeave through April 2032. This strategic alliance further solidifies CoreWeave's position in the AI infrastructure market, complementing its existing multi-billion dollar contracts with major players like OpenAI and Meta Platforms (META).
OPEC Output Rises, But Future Hikes Paused
A recent survey indicates that OPEC's oil output continued to increase last month, with October production reaching 28.43 million barrels per day (bpd), up 30,000 bpd from September, primarily driven by increases from Saudi Arabia and Iraq. Earlier surveys also showed a rise of 360,000 bpd in August to 27.84 million bpd from July, and a 400,000 bpd increase in September. However, OPEC+ (OPEC and its allies) has agreed to a modest 137,000 bpd increase for November and a temporary halt to further planned production increases for the first quarter of 2026. This pause, led by Saudi Arabia and Russia, signals caution regarding seasonally weaker demand and forecasts of substantial global inventory builds, despite Brent crude trading near $65 a barrel.
Warner Bros Discovery Delivers Mixed Q3 Performance
Warner Bros Discovery (WBD) delivered a mixed bag of third-quarter financial results. The company reported 2.3 million net subscriber additions, falling short of the estimated 2.54 million. Total revenue came in at $9.05 billion, missing the $9.19 billion estimate, while streaming revenue also missed expectations at $2.63 billion against an estimated $2.78 billion. Adjusted EBITDA was $345 million, below the estimated $354.8 million. However, a bright spot was the company's robust free cash flow, which reached $701 million, significantly exceeding the analyst estimate of $443.8 million.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.